Table IV.
Complete data scenario |
Missing data scenario |
|||||||
---|---|---|---|---|---|---|---|---|
Study | Method | Pooled estimates | 95% CI | p-value | Pooled estimates | 95% CI | p-value | |
Sasse † | Riley method | 0.312 | (0.104, 0.519) | 0.003 | — | — | — | |
Pseudo-REML | 0.320 | (0.054, 0.585) | 0.018 | — | — | — | ||
Zhao 2012‡ | Riley method | −0.078 | (−0.387, 0.232) | 0.623 | −0.281 | (−0.688, 0.126) | 0.176 | |
Pseudo-REML | −0.075 | (−0.377, 0.228) | 0.627 | −0.300 | (−0.928, 0.328) | 0.349 | ||
Thompson 2005* | Riley method | 0.055 | (−0.050, 0.160) | 0.304 | 0.072 | (0.024, 0.121) | 0.004 | |
Pseudo-REML | 0.076 | (−0.030, 0.181) | 0.159 | 0.070 | (0.030, 0.110) | 0.001 |
The pooled estimate is the difference between the log-hazard ratio with respect to the overall survival and disease-free survival.
The pooled estimate is the difference between the standard mean difference comparing cases and controls of paraoxonase activity and that of arylesterase activity.
The pooled estimate is logORTT vs CC/δP, which is the effect of one unit change in homocysteine level on logORTT vs CC.